Hwail Pharmaceutical Co.,Ltd.
Research Hwail Pharmaceutical Co.,Ltd. (061250.KQ) on Bullrun: market cap KRW 52.92B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker061250.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 52.92B
- Financial periodQ2 2026
- RevenueKRW 24.46B
- Net incomeKRW 4.37B
- Gross margin8.2%
Valuation Snapshot
latest market cap is KRW 52.92B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | KRW 7.88B | n/a | n/a | KRW 61.47B | KRW 335.34M | KRW 206.87B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | KRW 52.92B | n/a | n/a | n/a |
About Hwail Pharmaceutical Co.,Ltd.
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hwail Pharmaceutical Co.,Ltd.'s market cap?
Hwail Pharmaceutical Co.,Ltd.'s market capitalization is KRW 52.92B.
What does Hwail Pharmaceutical Co.,Ltd. do?
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.